Robotic leg device shows promise for helping muscle disease patients walk
NCT ID NCT05199246
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a powered leg exoskeleton (Keeogo) in 50 people with various muscle disorders to see if it is safe and helps them walk better. Participants performed walking tests with and without the device. The goal was to see if the device could improve walking distance and speed without causing harm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lower-limb powered dermoskeleton (Keeogo exoskeleton)
- What this could lead to
- If successful, this exoskeleton could help people with muscle weakness walk better and more safely, possibly improving daily mobility.
- What could go wrong
- This was a small, short-term safety study. The device may not work for all types or severities of muscle disorders, and long-term benefits are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL MYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Myology
Paris, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Worldwide data pool could pave the way for mitochondrial disease trials
- Engineered immune cells take aim at childhood autoimmune diseases
- New tool could predict who will suffer from steroid side effects